Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications

Clinical pharmacogenomics implementation in Thailand: a dream come true

(2023) Chonlaphat Sukasem et al.   PHARMACOGENOMICS

Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions

(2022) Beibei Gao et al.   BMC Medical Genomics

Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis

(2022) Mohitosh Biswas et al.   PHARMACOGENOMICS

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis

(2022) Mohitosh Biswas et al.   CTS-Clinical and Translational Science

Association of UGT1A1*6 , UGT1A1*28 , or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis

(2022) Chalirmporn Atasilp et al.   CTS-Clinical and Translational Science

Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder

(2022) Mohitosh Biswas et al.   PHARMACOGENOMICS

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

(2022) Napatrupron Koomdee et al.   Frontiers in Pharmacology

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

(2022) Mohitosh Biswas et al.   Frontiers in Pharmacology

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines

(2021) Heshu Abdullah-Koolmees et al.   Frontiers in Pharmacology

Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis

(2021) Mohitosh Biswas et al.   CARDIOVASCULAR DRUGS AND THERAPY

Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings

(2021) Chonlaphat Sukasem et al.   Drug Metabolism and Pharmacokinetics

Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in COVID-19 patients

(2021) Mohitosh Biswas   PHARMACOGENOMICS

Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis

(2021) Mohitosh Biswas et al.   International Journal of Clinical Pharmacy

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

Potential clinically significant drug‐drug interactions of hydroxychloroquine used in the treatment of COVID‐19

(2021) Mohitosh Biswas et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine

(2021) Chiraphat Kloypan et al.   Pharmaceuticals

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

(2020) Eva Schrezenmeier et al.   Nature Reviews Rheumatology

Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection

(2020) David N. Juurlink   CANADIAN MEDICAL ASSOCIATION JOURNAL

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base

(2020) Fabio S Taccone et al.   Lancet Respiratory Medicine

Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis

(2020) Mohitosh Biswas et al.   PLATELETS

Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic review and meta-analysis

(2020) Mohitosh Biswas et al.   Expert Opinion On Drug Safety

Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications

(2020) Mohitosh Biswas   PHARMACOGENOMICS JOURNAL

The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later

(2019) Mary V. Relling et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The effect of SNPs in CYP450 in chloroquine/primaquinePlasmodium vivaxmalaria treatment

(2016) Vinicius A Sortica et al.   PHARMACOGENOMICS

Pharmacogenomics in the clinic

(2015) Mary V. Relling et al.   NATURE

A New Initiative on Precision Medicine

(2015) Francis S. Collins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

(2015) M. Jallouli et al.   Arthritis & Rheumatology

Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus

(2015) Ji Yeon Lee et al.   Arthritis & Rheumatology

Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process

(2014) Kelly Caudle et al.   CURRENT DRUG METABOLISM

Clinical and Pharmacogenetic Influences on Response to Hydroxychloroquine in Discoid Lupus Erythematosus: A Retrospective Cohort Study

(2011) Shyamal Wahie et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY